T. Rowe Price has announced an exclusive distribution partnership with UBS Global Wealth Management (GWM) through which the Swiss lender will offer the T. Rowe Price Health Sciences Equity Strategy to its private wealth clients in Hong Kong and Singapore. The strategy, which was incepted in 1995, is dedicated to investing in health sciences companies and has US$ 19.3 billion in…
To access this content, please click back to the home screen, then click “Menu” (bars in top left bars) and then “Login”.
To enquire for a free trial, please start here.
Need more help? Click here or email [email protected].
Subscriber Only Content
This article is available on a corporate subscription with Asian Private Banker. Please login or subscribe to view this content.
Need help? Please see our FAQ Guide or email [email protected]